Nifty
Sensex
:
:
11521.05
38386.75
-11.35 (-0.10%)
23.28 (0.06%)

Pharmaceuticals & Drugs

Rating :
59/99

BSE: 531633 | NSE: LINCOLN

206.00
-10.60 (-4.89%)
20-Mar-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  209.00
  •  213.85
  •  203.75
  •  216.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  146311
  •  301.40
  •  314.40
  •  157.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 411.20
  • 8.74
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 457.90
  • 0.73%
  • 1.58

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.39%
  • 13.38%
  • 45.94%
  • FII
  • DII
  • Others
  • 0.15%
  • 0.00%
  • 8.14%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.20
  • 11.37
  • -3.41

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.32
  • 21.63
  • 5.68

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.16
  • 26.59
  • 13.50

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.88
  • 11.66
  • 12.96

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.30
  • 1.75
  • 2.03

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.99
  • 7.64
  • 8.26

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Net Sales
84.44
80.18
5.31%
102.60
89.65
14.45%
99.82
150.23
-33.56%
67.13
120.67
-44.37%
Expenses
70.83
64.03
10.62%
83.52
74.22
12.53%
76.53
143.22
-46.56%
57.48
116.88
-50.82%
EBITDA
13.61
16.15
-15.73%
19.09
15.43
23.72%
23.30
7.01
232.38%
9.65
3.79
154.62%
EBIDTM
16.12%
20.14%
18.60%
17.21%
23.34%
4.67%
14.38%
3.14%
Other Income
0.38
2.83
-86.57%
4.43
2.99
48.16%
2.30
2.84
-19.01%
0.86
0.21
309.52%
Interest
0.71
1.37
-48.18%
1.75
1.50
16.67%
1.33
1.61
-17.39%
0.94
1.42
-33.80%
Depreciation
1.94
1.39
39.57%
1.51
1.81
-16.57%
1.58
1.38
14.49%
1.53
1.39
10.07%
PBT
11.34
16.22
-30.09%
20.26
15.12
33.99%
22.68
6.87
230.13%
8.04
1.19
575.63%
Tax
2.20
4.64
-52.59%
5.25
3.80
38.16%
6.60
1.95
238.46%
1.21
-0.14
-
PAT
9.14
11.58
-21.07%
15.01
11.32
32.60%
16.07
4.92
226.63%
6.83
1.32
417.42%
PATM
10.83%
14.45%
14.63%
12.63%
16.10%
3.27%
10.17%
1.10%
EPS
4.57
5.79
-21.07%
7.50
5.65
32.74%
8.03
2.46
226.42%
3.42
0.63
442.86%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
353.99
360.61
360.26
400.15
266.07
210.49
194.70
187.58
176.51
124.34
114.02
Net Sales Growth
-19.68%
0.10%
-9.97%
50.39%
26.41%
8.11%
3.80%
6.27%
41.96%
9.05%
 
Cost Of Goods Sold
159.26
173.47
202.90
254.64
161.12
123.72
113.96
111.61
105.50
62.40
67.25
Gross Profit
194.73
187.14
157.35
145.50
104.96
86.77
80.74
75.97
71.01
61.94
46.77
GP Margin
55.01%
51.90%
43.68%
36.36%
39.45%
41.22%
41.47%
40.50%
40.23%
49.82%
41.02%
Total Expenditure
288.36
307.19
313.52
359.62
240.47
190.42
179.22
174.08
166.98
113.18
104.89
Power & Fuel Cost
-
6.82
5.92
5.68
4.27
3.40
2.12
0.73
0.68
1.07
0.89
% Of Sales
-
1.89%
1.64%
1.42%
1.60%
1.62%
1.09%
0.39%
0.39%
0.86%
0.78%
Employee Cost
-
51.15
37.59
28.83
17.87
18.57
17.71
16.52
14.30
9.89
7.29
% Of Sales
-
14.18%
10.43%
7.20%
6.72%
8.82%
9.10%
8.81%
8.10%
7.95%
6.39%
Manufacturing Exp.
-
34.69
29.44
35.81
25.98
19.10
17.54
16.91
16.31
13.29
7.40
% Of Sales
-
9.62%
8.17%
8.95%
9.76%
9.07%
9.01%
9.01%
9.24%
10.69%
6.49%
General & Admin Exp.
-
17.50
14.78
20.34
18.86
15.07
13.25
13.36
7.77
13.61
12.33
% Of Sales
-
4.85%
4.10%
5.08%
7.09%
7.16%
6.81%
7.12%
4.40%
10.95%
10.81%
Selling & Distn. Exp.
-
21.24
19.91
10.10
9.42
8.42
13.22
13.66
22.18
12.84
8.98
% Of Sales
-
5.89%
5.53%
2.52%
3.54%
4.00%
6.79%
7.28%
12.57%
10.33%
7.88%
Miscellaneous Exp.
-
2.33
2.97
4.22
2.95
2.13
1.43
1.28
0.25
0.08
8.98
% Of Sales
-
0.65%
0.82%
1.05%
1.11%
1.01%
0.73%
0.68%
0.14%
0.06%
0.68%
EBITDA
65.65
53.42
46.74
40.53
25.60
20.07
15.48
13.50
9.53
11.16
9.13
EBITDA Margin
18.55%
14.81%
12.97%
10.13%
9.62%
9.53%
7.95%
7.20%
5.40%
8.98%
8.01%
Other Income
7.97
4.34
2.78
7.36
7.19
2.49
6.40
3.36
3.30
1.26
0.20
Interest
4.73
5.41
6.66
9.96
8.38
6.97
7.84
7.60
4.98
2.68
1.80
Depreciation
6.56
6.11
5.51
4.87
4.57
3.53
2.65
1.93
1.67
1.16
0.86
PBT
62.32
46.25
37.33
33.07
19.85
12.07
11.38
7.33
6.18
8.58
6.66
Tax
15.26
11.60
9.20
9.27
4.80
1.89
1.85
2.20
2.01
2.48
2.35
Tax Rate
24.49%
25.08%
24.65%
28.03%
24.18%
15.66%
16.26%
30.01%
32.52%
28.90%
35.29%
PAT
47.05
34.62
28.12
23.68
15.01
10.65
9.66
5.12
4.17
6.10
4.31
PAT before Minority Interest
47.04
34.65
28.13
23.80
15.04
10.18
9.53
5.13
4.17
6.10
4.31
Minority Interest
-0.01
-0.03
-0.01
-0.12
-0.03
0.47
0.13
-0.01
0.00
0.00
0.00
PAT Margin
13.29%
9.60%
7.81%
5.92%
5.64%
5.06%
4.96%
2.73%
2.36%
4.91%
3.78%
PAT Growth
61.46%
23.12%
18.75%
57.76%
40.94%
10.25%
88.67%
22.78%
-31.64%
41.53%
 
Unadjusted EPS
23.52
17.31
15.73
14.52
9.20
6.53
5.92
3.14
3.02
6.71
5.66

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
224.22
192.38
140.52
111.31
98.81
89.30
80.78
76.82
53.29
36.44
Share Capital
20.00
20.00
16.31
16.31
16.31
16.31
16.31
16.31
11.31
7.61
Total Reserves
204.22
172.38
116.65
95.00
82.50
72.99
64.47
60.50
41.98
27.83
Non-Current Liabilities
24.94
31.75
33.74
33.14
26.18
25.14
22.37
11.22
29.98
17.81
Secured Loans
6.93
12.38
23.62
15.27
16.20
14.41
12.33
2.54
25.61
12.00
Unsecured Loans
0.00
0.00
0.00
10.21
3.04
2.66
1.97
1.57
1.51
3.58
Long Term Provisions
7.19
9.98
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
113.43
99.42
100.34
114.47
131.05
118.26
104.86
77.24
27.67
18.78
Trade Payables
43.48
32.46
30.38
45.31
66.51
47.51
42.05
22.63
17.61
10.84
Other Current Liabilities
11.05
12.77
15.10
11.52
14.15
15.57
16.25
12.25
3.68
0.63
Short Term Borrowings
48.55
45.04
52.62
50.67
48.46
54.90
46.56
40.35
0.00
0.00
Short Term Provisions
10.36
9.15
2.24
6.97
1.92
0.27
0.00
2.01
6.38
7.32
Total Liabilities
362.92
323.85
274.79
261.85
259.75
236.88
212.31
165.28
110.94
73.03
Net Block
116.58
102.71
98.47
65.62
65.07
64.94
37.74
27.96
21.01
16.87
Gross Block
127.65
108.16
120.89
87.50
82.22
78.82
49.07
36.70
27.67
22.47
Accumulated Depreciation
11.08
5.45
22.42
21.88
17.15
13.89
11.33
8.74
6.66
5.61
Non Current Assets
136.08
134.27
127.83
80.64
110.69
113.67
90.73
45.38
22.14
16.87
Capital Work in Progress
0.29
6.63
2.73
2.55
2.37
2.37
13.51
4.14
1.13
0.00
Non Current Investment
0.09
0.09
0.01
0.01
0.41
0.41
0.41
0.00
0.00
0.00
Long Term Loans & Adv.
18.79
24.48
26.62
12.47
42.84
45.95
39.08
13.28
0.00
0.00
Other Non Current Assets
0.34
0.36
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.00
Current Assets
226.83
189.58
146.98
181.20
149.06
123.21
121.58
119.90
88.78
56.15
Current Investments
10.97
10.25
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
45.41
37.31
27.48
21.82
23.84
19.33
21.41
26.07
22.97
14.31
Sundry Debtors
109.44
90.67
80.53
119.01
89.04
74.79
65.37
40.08
31.38
22.98
Cash & Bank
14.59
11.68
12.66
11.51
10.45
15.15
16.86
13.14
13.49
4.60
Other Current Assets
46.42
0.66
0.05
0.00
25.73
13.94
17.94
40.61
20.94
14.25
Short Term Loans & Adv.
45.13
39.02
26.26
28.86
25.73
13.94
17.94
40.61
20.94
14.25
Net Current Assets
113.40
90.16
46.63
66.73
18.01
4.95
16.72
42.66
61.11
37.36
Total Assets
362.91
323.85
274.81
261.84
259.75
236.88
212.31
165.28
110.93
73.03

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
23.15
25.04
44.80
24.56
4.64
-15.60
11.87
-34.26
-10.55
1.53
PBT
46.25
37.33
33.07
19.85
12.07
9.53
5.13
8.24
8.58
6.66
Adjustment
11.64
10.70
13.75
10.68
12.75
8.96
14.32
7.27
1.21
2.05
Changes in Working Capital
-25.49
-13.24
4.80
-2.50
-17.56
-32.36
-6.38
-48.08
-17.98
-4.81
Cash after chg. in Working capital
32.40
34.79
51.62
28.02
7.26
-13.87
13.07
-32.58
-8.19
3.90
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-9.25
-9.75
-6.82
-3.46
-2.62
-1.73
-1.20
-1.68
-1.85
-1.65
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-8.29
-25.48
-41.79
6.52
1.45
-16.27
-27.23
-10.89
-6.02
-3.61
Net Fixed Assets
-12.45
4.05
-29.04
-4.21
-0.95
-2.89
-4.61
-12.04
-6.33
Net Investments
-2.72
-16.01
-7.34
-1.43
0.00
0.00
-11.16
0.00
0.00
Others
6.88
-13.52
-5.41
12.16
2.40
-13.38
-11.46
1.15
0.31
Cash from Financing Activity
-11.41
0.30
-3.42
-32.04
-10.51
29.30
16.19
45.06
25.45
3.37
Net Cash Inflow / Outflow
3.45
-0.14
-0.41
-0.96
-4.42
-2.57
0.82
-0.09
8.89
1.28
Opening Cash & Equivalents
3.12
3.26
3.75
4.82
9.39
11.97
11.53
11.62
4.60
3.32
Closing Cash & Equivalent
6.57
3.12
3.43
3.87
4.97
9.39
12.36
11.53
13.49
4.60

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
112.11
96.19
81.52
68.24
60.58
54.75
49.53
47.10
47.10
46.55
ROA
10.09%
9.40%
8.87%
5.77%
4.10%
4.25%
2.72%
3.02%
6.64%
5.90%
ROE
16.63%
17.29%
19.49%
14.32%
10.83%
11.21%
6.51%
6.41%
13.76%
12.16%
ROCE
19.05%
18.51%
21.18%
15.91%
11.48%
12.21%
10.94%
10.97%
17.01%
16.28%
Fixed Asset Turnover
3.07
3.19
3.90
3.20
2.67
3.10
4.45
5.60
5.05
5.07
Receivable days
100.99
85.52
89.69
139.97
139.16
128.96
100.92
72.36
78.28
73.58
Inventory Days
41.74
32.36
22.16
30.72
36.67
37.48
45.44
49.66
53.69
45.82
Payable days
47.65
37.21
40.22
92.31
115.76
98.21
75.46
45.35
48.51
40.94
Cash Conversion Cycle
95.08
80.67
71.63
78.37
60.06
68.23
70.90
76.67
83.46
78.46
Total Debt/Equity
0.27
0.34
0.59
0.69
0.69
0.85
0.86
0.60
0.51
0.44
Interest Cover
9.55
6.60
4.32
3.37
2.73
2.45
1.96
2.24
4.21
4.70

News Update:


  • CRISIL assigns ratings to Lincoln Pharmaceuticals’ bank facilities
    19th Mar 2019, 14:17 PM

    The agency has assigned rating of ‘A2+’ to the company’s short term bank loan facilities

    Read More
  • Lincoln Pharma - Quarterly Results
    12th Feb 2019, 13:15 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.